Market Updates, Regulations

UNPA to Host NDI Guidance Workshop Sep. 8

Economic cost to industry could be billions of dollars, according to Loren Israelsen.

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

In response to the Aug. 11 publication of a revised new dietary ingredient (NDI) guidance by the Food and Drug Administration (FDA), the United Natural Products Alliance (UNPA) will conduct a one-day, immersive workshop in Salt Lake City, UT, on Thursday, Sep. 8, to analyze the 102-page document that fundamentally changes the regulatory status of thousands of dietary ingredients and dietary supplements.

The workshop, “NDI GUIDANCE II & Substances Generally Recognized as Safe,” will include a presentation from and participation in extended Q&A sessions from Cara Welch, PhD, senior advisor for the Office of Dietary Supplement Programs. The conference, which will include case studies, audience polling and a comprehensive workbook, will address issues and concerns around a large number of the expected and not-expected provisions in the draft guidance, including:

  • Official FDA ODI List
  • NDI triggers
  • ‘Master Files’
  • Synthetic botanicals
  • Impact on probiotics
  • ‘Manufacturing Changes’
  • Budgeting for safety studies
  • ‘Chemical Alteration’

“Based on our initial analysis, FDA has structured this guidance to create a vastly larger universe of NDIs by virtue of limiting chemical alteration of food and food ingredients in the human diet and by treating most manufacturing changes as a trigger for NDI status,” said UNPA President Loren Israelsen, who will present a detailed overview of the guidance document. “The economic cost to industry could be billions of dollars. Understanding and responding to this FDA policy is an urgent priority.”
  • Workshop topics include:
  • The revised NDI guidance explained, plus FDA’s real-time responses
  • ODI/NDI determinations and associated costs
  • The intersection of NDIs and GRAS
  • Guidance vs. regulation: FDA’s enforcement game plan
  • Does Congress have a role in this process?
  • Cost implications and impacts

“With the current comment period set to close Oct. 11, there is a great urgency to examine, understand and prepare comments as well as enhance individual company readiness to deal with NDIs—the No. 1 issue for the dietary supplement industry,” Mr. Israelsen added.

For more information, the agenda, lodging information and to register, view/download the workshop program, or visit the UNPA website.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters